IMMUTEP Ltd (IMMP) stock
IMMPNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRRUF
$3.48−0.17 (-4.79%)
Close on Nov 13, 2026Market cap $25.64MP/E –Yield –
Immutep total assets
Total assets on the balance sheet at the end of each period.
Immutep's total assets was A$83.27M at Jun 30, 2026. For fiscal 2026 it was A$83.27M, down 47.0% from the year before. Over ten years it grew 6.9% a year on average. The highest annual figure on record is A$201.58M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | A$83.27M | -47.0% |
| FY2025 | Jun 30, 2025 | A$156.98M | -22.1% |
| FY2024 | Jun 30, 2024 | A$201.58M | +36.7% |
| FY2023 | Jun 30, 2023 | A$147.45M | +44.3% |
| FY2022 | Jun 30, 2022 | A$102.17M | +24.6% |
| FY2021 | Jun 30, 2021 | A$82.03M | +76.0% |
| FY2020 | Jun 30, 2020 | A$46.60M | +14.9% |
| FY2019 | Jun 30, 2019 | A$40.54M | -13.7% |
| FY2018 | Jun 30, 2018 | A$47.00M | +34.4% |
| FY2017 | Jun 30, 2017 | A$34.96M | -17.8% |
| FY2016 | Jun 30, 2016 | A$42.55M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | A$83.27M | -18.5% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | A$156.98M | +91.4% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | A$201.58M | +332.6% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | A$147.45M | +263.7% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | A$102.17M | +117.4% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | A$82.03M | +134.6% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | A$46.60M | +9.5% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | A$40.54M | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | A$47.00M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | A$34.96M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | A$42.55M | – |
See a number that looks wrong?